Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

MicroRNA-mediated regulation of melanoma.

The British journal of dermatology·2014

Same author

Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cells.

Cancer gene therapy·2005

Same author

Hammerhead ribozymes as therapeutic agents for bladder cancer.

Molecular urology·2002

Same author

A modified staging classification for cutaneous T-cell lymphoma.

Journal of the American Academy of Dermatology·2001

Same author

Vascular involvement in the prognosis of primary cutaneous melanoma.

Archives of dermatology·2001

Same author

Early experience with sentinel lymph node mapping for Merkel cell carcinoma.

Journal of the American Academy of Dermatology·2001

Search research articles

Related Experiment Video

Updated: May 10, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Molecular markers in melanoma.

M Kashani-Sabet¹

¹Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, 475 Brannan St., Suite 220, San Francisco, CA, 94107, U.S.A.

The British Journal of Dermatology

|July 3, 2013

Summary

Melanoma treatment is advancing with new molecular markers for diagnosis and prognosis. These molecular assessments aid in personalized therapy for advanced melanoma, improving patient outcomes.

Area of Science:

Oncology
Molecular Biology
Dermatology

Background:

The molecular era in melanoma treatment has emerged, driven by targeted therapies like BRAF inhibitors.
Advances in molecular assessment are crucial for understanding melanoma progression and guiding therapy.
Genome-wide approaches are increasingly used to interrogate the malignant phenotype of melanoma.

Purpose of the Study:

To review recent progress in novel molecular marker development for melanoma.
To discuss advances in molecular classification, diagnosis, and prognosis of melanoma.
To highlight molecular markers nearing clinical application in melanoma management.

Main Methods:

Comparative genomic hybridization (CGH) for DNA-level analysis.
Gene expression profiling for RNA-level analysis.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Experiment Videos

Last Updated: May 10, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for marker validation.

Main Results:

Identification of novel molecular markers through genome-wide approaches.
Development of platforms for molecular assessment of melanoma progression.
Progress in molecular classification, diagnosis, and prognosis of melanoma.

Conclusions:

Novel molecular markers are rapidly advancing towards clinical application in melanoma.
Molecular assessment is pivotal for personalized melanoma therapy and improved prognosis.
Melanoma research is at the forefront of molecularly targeted cancer treatment.